Johnson & Johnson Innovation has announced that it is expanding its global Incubator presence through a novel collaboration with the Office of the Chief Scientist in Israel and other industry partners to establish a new biotechnology incubator near Israel’s Weizmann Science Park.
The outcome of the collaboration among Johnson & Johnson Innovation and Johnson & Johnson Development Corporation (JJDC), the Office of the Chief Scientist in Israel, Takeda Pharmaceutical Company, and OrbiMed Israel Partners, is a public-private biotechnology incubator that will be located near the Weizmann Science Park, Rehovot, Israel.
The Weizmann Science Park area is considered to be one of the foremost centers in the world for multidisciplinary research, and is the location of a Johnson & Johnson Innovation satellite office.
The new incubator, which will be operational in early 2014, is the latest in a series of recently announced collaborations with other biotechnology incubators to fuel entrepreneurship, including Montreal-based NEOMED; Toronto-based MaRS Innovation; San Francisco-based California Institute for Quantitative Biosciences (QB3); and Boston-based LabCentral.
To find out more on click here!